Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;25(7):527-538.
doi: 10.2174/0113892037284176240302052521.

Research Progress on Extracellular Matrix Involved in the Development of Preeclampsia

Xin Wang  1   2 , Qi Zhang  3 , Yi Ren  1 , Chao Liu  2 , Huijie Gao  2
Affiliations
Review

Research Progress on Extracellular Matrix Involved in the Development of Preeclampsia

Xin Wang et al. Curr Protein Pept Sci. 2024.

Abstract

Preeclampsia (PE) is a serious pregnancy complication, and its primary clinical manifestations are gestational hypertension and proteinuria. Trophoblasts are responsible for the basic functions of the placenta during placental development; recent studies have revealed that placental "shallow implantation" caused by the decreased invasiveness of placental trophoblasts plays a crucial role in PE pathogenesis. The interaction between the cells and the extracellular matrix (ECM) plays a crucial role in trophoblast proliferation, differentiation, and invasion. Abnormal ECM function can result in insufficient migration and invasion of placental trophoblasts, thus participating in PE. This article summarizes the recent studies on the involvement of ECM components, including small leucine-rich proteoglycans, syndecans, glypicans, laminins, fibronectin, collagen, and hyaluronic acid, in the development of PE. ECM plays various roles in PE development, most notably by controlling the activities of trophoblasts. The ECM is structurally stable and can serve as a biological diagnostic marker and therapeutic target for PE.

Keywords: Preeclampsia; extracellular matrix; matrix metalloproteinases.; placenta; proteoglycans; trophoblast.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Van Rijn B. B.; Bruinse H. W.; Veerbeek J. H.; Post Uiterweer E. D.; Koenen S. V.; Van der Bom J. G.; Rijkers G. T.; Roest M.; Franx A.; Postpartum circulating markers of inflammation and the systemic acute-phase response after early-onset preeclampsia. Hypertension 2016,67(2),402-414 - DOI
    1. Rana S.; Lemoine E.; Granger J.P.; Karumanchi S.A.; Preeclampsia: Pathophysiology, challenges, and perspectives. Circ Res 2019,124(7),1094-1112 - DOI - PubMed
    1. Chappell L.C.; Cluver C.A.; Kingdom J.; Tong S.; Pre-eclampsia. Lancet 2021,398(10297),341-354 - DOI - PubMed
    1. Liu M.; Yin Y.; Yu H.; Zhou R.; Laminins regulate placentation and pre-eclampsia: Focus on trophoblasts and endothelial cells. Front Cell Dev Biol 2020,8,754 - DOI - PubMed
    1. Stevens D. U.; Al-Nasiry S.; Bulten J.; Spaanderman M. E.; Decidual vasculopathy in preeclampsia: Lesion characteristics relate to disease severity and perinatal outcome. Placenta 2013,34(9),805-809 - DOI

LinkOut - more resources